We analyzed 2M+ pharmaceutical payments to clinical sites and mapped them back to 10,000 clinical trials. The big takeaway: cost per site has been relatively stable since 2014, despite a massive increase in protocol complexity.
If we had a LinkedIn follower for every new AI-powered drug discovery company we come across... Last week, Anthropic revealed Claude Science, an AI workbench for scientists, setting off another round of discussion around frontier labs' role in the future of AI drug discovery.
The clinical world is full of questions, exceptions, and ambiguity. We built Rightview CRX to help coordinators navigate it.
We're excited to announce the launch of Rightview CRx — a one-of-its-kind free regulatory Q&A resource built for busy clinical research professionals.
At this point, no one is unfamiliar with the convenience of modern AI tools. We use it everywhere, outsourcing tedious tasks so that we're unlocked to do bigger, better things. The ROI is obvious, but the risks are not.
